Howell accepts Lewis Rudin Glaucoma Prize Inter-Institutional Symposium: Biomedical Engineering & GeneticsOur discoveries were honored with the Lewis Rudin Glaucoma Prize for the paper: Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest 122(4):1246–1261. It is a great honor that Dr. Gareth Howell accepted this award on our behalf. March 2013 Dr. Gareth Howell receives Shaffer Prize for innovative glaucoma research to read more Spring 2013 August 2012 John is featured in Search magazine to read more August 2012 Gambling on Transformative Research - (Science Careers) In this article, Dr. John is interviewed and provides advice for young investigators. He is truly appreciative and thankful for this opportunity. He wishes to highlight the contributions of his engineering collaborators, Dr. Pedro Irazoqui and Dr. William Chappell of Purdue University to this research. They are essential for this research, which is not possible without them. to read more September 2011 Dr. Gareth Howell is awarded NIH R01 funding to study the complement cascade in glaucoma May 2011 John Lab discovers a gene for Angle Closure Glaucoma Paper published in Nature Genetics March 2011 Research linking RNA granules to juvenile cataracts and glaucoma published in Science March 2011 Howell and John appear on local NBC station WLBZ2 to discuss new research detecting early stages of glaucoma Howell granted Thomas R. Lee Award for National Glaucoma Research Howell's award from the American Health Assistance Foundation will support his research to asses the importance of the Endothelin System in glaucoma, specifically its role as a mechanism of neuronal cell death. The research will use a mouse model of heritable glaucoma, concentrating on early stages of the disease, prior to significant neuronal cell loss. Endothlelins are known to influence blood pressure. Howell's work shows that Endothelins change very early on in glaucoma and could even be driving pathogenesis. This work has the potential to lead to improved therapies for human glaucoma. February 2010 John invited to lecture at 40th Anniversary Celebration of the National Eye Institute to read more to view program John invited to lecture at Cardiff University for 125th Anniversary to read more November 2008 HHMI awards $40 million dollars for unique collaboration John awarded Collaborative Innovation Award for work with Purdue engineers on ultra-miniature sensors. to read more September 2008 Partridge Foundation grants $1.25 million to John for radiation based neuroprotection to read more August 2008 Alcon Research Institute Award John is one of seven researchers recognized by the Alcon Research Institute of Fort Worth, Texas, for dedicating their lives to enhancing the understanding of vision and eye health. These seven doctors, who were nominated by previous winners and selected by ARI’s independent Scientific Selection Committee, will receive $100,000 in unrestricted grant money from the ARI to continue pursuing their research into the underlying causes of eye disease. They also will be recognized at the ARI’s biennial symposium in 2009, where they will present their research to all of the members of the ARI. (adapted from JAX press release) December 2006 John accepts 2005 World Glaucoma Association (WGA) Science Award for radiation
paper and his creative and breakthrough body of research on glaucoma to read more April 2006 Research finds genetically weakened blood vessels may increase danger of certain type of stroke Findings published in The New England Journal of Medicine to read more May 2005 John Lab finds genetic link to cerebral hemorrhage and brain disease in infants to read more April 2005 John Lab discovers gene mutation that leads to cerebral hemorrhaging Paper published in Science to read more March 2005 Radiation with bone marrow transplant prevents neurodegeneration in inherited glaucoma Important findings published in Proceedings of the National Academy of Sciences to read more April 2004 John awarded ARVO's Cogan Award The Cogan Award is presented annually to a researcher of 40 years of age or younger, who has made important and worthwhile contributions to research in ophthalmology or visual science that are directly related to disorders of the human eye or visual system, and who shows substantial promise for future research. Dr. John has been selected to receive this honor for his important contributions in the development, analysis and use of mouse models for genetic and therapeutic studies of glaucoma. Dr. John will receive the award and present the Cogan Lecture on Tuesday, April 27 at the 2004 ARVO Annual Meeting in Fort Lauderdale, Florida. (adapted from JAX press release) March 2003 John Lab discovers important gene in inherited glaucoma Findings published in Science to read more May 1997 John selected to be a Howard Hughes Medical Institute Investigator to read more |